In the present research, we demonstrated that MALAT1 level was upregulated only in esophageal cancer, acute myeloid leukemia, and stomach adenocarcinoma, and widely low expressed in most kinds of cancers, including lung cancer etc., by GEPIA. Here, MALAT1 is linked to lung carcinoma.